The work doesn't stop at the science.
It stacks around it.
Investor updates. Pitch decks. Advisory boards. Publications. Conferences. Each one needs clear, credible content for a different audience, every time.
Build like a startup.
Communicate like big pharma.
You're early-stage. The bar isn't. Qoolo gives life sciences founders the content infrastructure to communicate like they've already scaled: compliant, credible, and fast, without the overhead.
You're early-stage.
The expectations aren't.
Every early- and mid-stage life sciences founder faces the same reality: limited resources, relentless expectations, no time to slow down. You’re building the company - advancing R&D, navigating regulatory hurdles, and chasing inflection points that will make or break it. And more often than anyone admits, you’re still the one fixing decks at 11pm. Not because that’s your job, but because it has to get done.
The work doesn't stop at the science.
Commercializing changes everything.
Except your resources.
A product on the market, but no big field force.
No heavy CRMs. No agency retainers. Just a lean team
expected to show up like an enterprise.
The part no one talks about
You didn't start a biotech to become a PowerPoint expert, a graphic designer, or an IT troubleshooter. But somehow that's what fills your week.
Rebuilding the same story five times.
Investor deck. KOL presentation. Advisory board pre-read. Conference poster. Publication supplement. Same science, five formats, five audiences. Even simple updates take hours.
Every subscription is a trade-off.
CRM now or after the next round? Agency retainer or in-house scrambling? Enterprise software is priced for teams of ten-plus. You need big-pharma output without big-pharma overhead.
Compliance consumes time.
Every claim needs a reference. Every reference needs formatting. Every update needs review. Regulatory accuracy is not optional, but managing it manually can take weeks.
Analytics. I wish.
The deck goes out. The link gets opened. Then silence. Did they engage? Which section mattered? Follow-up stays guesswork when the content cannot tell you what happened.
Your story evolves. Your materials don’t.
New safety data comes in. A key hire changes the story. A partnership shifts your positioning. But your investor deck still shows last quarter’s milestones. You’re pitching tomorrow. Everything needs updating... tonight.
Which slide deck did I send?
The investor has version 3. Your advisor has version 5. Your team is working on version 7. MLR approved version 4, but that's missing the new partnership slide. One wrong file sent to the wrong person can cost you a deal.
Struggling with these issues?
Let's talk and see how Qoolo could help your team.
You don't need a bigger team.
You need better infrastructure.
You're five people doing the work of twenty. Fixing decks at midnight. Rebuilding the same science for every audience. Choosing between looking credible and protecting your runway.
Operate bigger than you are with Qoolo. Turn your science into compliant, mobile-first micro-content in hours, not weeks.
What five people can actually do with Qoolo?
(or 1, or 20...up to you)
Create content fast: drag, drop, done.
Turn pitch decks, trial updates, and board summaries or scientific data into polished, mobile-first content in hours, not weeks. No coding, no design team, no agency delays.
Make a change once. It updates everywhere.
Clinical decks, investor materials, KOL presentations, and commercial resources - all connected to the same source. Change your safety data in one place, and it reflects across every audience, every region, automatically.
References? Yes, compliance is built in.
Every piece of content you develop is structured, referenced, and version-controlled from the start. You don’t fix compliance later, compliance is part of how the content is built.
Always on-brand. Defined once. Everywhere.
Define your brand once - Qoolo applies it everywhere automatically. From investor decks, to conference materials, to internal updates, your content always looks consistent, credible, and compliant.
Send materials instantly and securely.
Distribute content to anyone - investors, HCPs, advisors, partners, or internal teams - through secure links or QR codes. Option to send via email, SMS, WhatsApp, Viber, or WeChat. The content mobile-first and available to people you choose.
See who opened what and what resonated.
Track and analyze how audiences engage with your content - what’s opened, read, and shared - so you can refine messages and follow up intelligently.
Scale without starting over.
As your story evolves with new data, new milestones, and new positioning, you can adapt existing content in minutes. New audiences, regions, or campaigns. No rebuilding. No reformatting. No wasted time.
Save time. Control burn.
Deliver professional, compliant scientific content fast and at scale without expanding your team or adding more tools. Money is scarce. So is your time. Protect both and move faster.
What can you build with Qoolo?
Pitch Decks
Turn your pitch deck into a mobile-first, always-updated story investors can review on the go.
One-Pagers & Fundraising Teasers
Send polished mobile-ready fundraising materials that summarize your science, pipeline, and opportunity before the full deck - perfect for warm introductions and conference follow-ups.
Term Sheet Summaries
Share key terms, valuation, structure, and timelines in a clear, mobile-first summary investors can review quickly, without forwarding sensitive PDFs or outdated versions.
Investor Updates
Replace long emails with structured investor updates that clearly communicate milestones, capital allocation, hiring progress, and clinical development timelines.
Clinical Trial Data Readouts
Share interim or top-line clinical trial results as concise, referenced summaries investors can scan and understand in minutes.
Regulatory & Clinical Milestones
Communicate IND submissions, FDA meetings, enrollment progress, safety updates, or Fast Track designations instantly - without resending new files every time something changes.
Advisory Board Pre-Reads
Send short, structured pre-read materials: including trial updates, key questions, and discussion points - in one mobile-ready link.
Advisory Feedback & Surveys
Collect structured feedback immediately after meetings through built-in surveys, without scattered emails or manual consolidation.
Clinical Data & Safety Updates
Share new trial results, safety findings, subgroup analyses, or regulatory updates as concise, referenced summaries experts can review between patients.
Study Protocol & Amendment Reviews
Circulate study protocols, endpoint refinements, or amendments in a structured format that makes expert review faster and more focused.
Publication & Abstract Summaries
Turn publications, congress abstracts, or manuscripts into digestible, mobile-first summaries without lengthy PDFs or logins.
Post-Meeting & Conference Follow-Ups
Send targeted follow-ups summarizing key takeaways, next steps, or additional data, keeping scientific conversations active long after the meeting ends.
Digital Posters
Turn congress posters into mobile-first, swipeable summaries accessible through QR codes, so your data lives beyond the poster board.
Booth-to-Go Experiences
Share your science through a single link or QR code that visitors can explore during and after the event.
Symposium Highlights & Slide Recaps
Share mobile-first summaries of your symposium presentation so attendees can revisit key slides, data, and references without taking photos of the screen.
Congress Data Recaps
Summarize new data presented at the meeting into concise, referenced updates you can share with investors, advisors, and partners immediately after.
Targeted Follow-Ups
Send personalized post-meeting follow-ups to HCPs, KOLs, or investors based on what they viewed, not generic mass emails.
Lead Capture & CRM Integration
Turn every conference interaction into a structured contact inside Qoolo CRM. Capture details instantly, track what content they viewed, and follow up based on real engagement.
New Hire Onboarding
Turn company overviews, scientific foundations, pipeline strategy, and compliance basics into short, structured, mobile-first onboarding modules new hires can review anytime, on the go.
Scientific & Clinical Training
Convert clinical data, MOA explanations, competitive landscape updates, and trial design details into concise, trackable training content your team can revisit as programs evolve.
Executive & Board Prep Materials
Prepare internal teams ahead of board meetings or major milestones with clear, up-to-date briefing materials, so everyone speaks the same language under pressure.
Cross-Functional Alignment Before Major Moments
Before conferences, investor meetings, data readouts, or partnership announcements, share internal briefings that align medical, commercial, and leadership teams on one clear message.
Clinical & Regulatory Update Briefings
When new trial data, safety findings, FDA feedback, or milestone shifts occur, share structured internal summaries that explain what changed and what it means.
Approved Claims & Content Control
Maintain a version-controlled internal library of approved claims, safety language, core slides, and referenced data so no one shares outdated, unapproved, or inconsistent information. When data changes, update it once. Everyone works from the latest, compliant version.
Infrastructure that grows with you
Most tools in the life sciences are built for big budgets, large teams, or late-stage companies, and often come with high complexity, high cost, or restrictive contracts. Early and mid-stage teams are left with solutions that are either out of reach, over-engineered, or not designed for their realities.
Qoolo changes that. Our platform is accessible from day one, designed for lean teams, and scales as you do, no matter your company’s size or stage. Whether you’re building your first one-pager or preparing for commercial launch, Qoolo removes barriers and grows with you. At every step, you get the functionality you need, without the complexity you don’t.
Establish credibility early
In early-stage biotech, credibility matters before scale. You’re refining your scientific narrative, presenting pre-clinical data, engaging scientific advisors, and preparing investor materials.
Qoolo helps you:
Establish a consistent brand and scientific foundation from the start.
Turn early data, abstracts, and advisory materials into structured, mobile-ready content.
Deliver professional investor and KOL communications without agency dependency.
Build trust before you build headcount.
Scale without losing control
As you move into clinical trials, regulatory interactions, and late-phase studies, complexity increases. More stakeholders. More content. More compliance pressure.
Qoolo supports:
Structured clinical trial and regulatory communications.
Engagement tracking across advisors, investors, and internal teams.
Version-controlled safety language, prescribing information, and milestone updates.
Growth shouldn’t mean operational chaos.
Launch and grow on the same infrastructure.
As your product approaches launch, communication multiplies. You’re educating HCPs, supporting medical affairs, enabling field teams, and expanding into new regions, while maintaining regulatory compliance.
With Qoolo, you can:
Option to reuse and localize approved promotional and medical materials.
Launch mobile-first educational content for HCPs and partners.
Maintain centralized version control and audit-ready tracking.
Push updated prescribing information and safety content instantly.
Scale your communication without rebuilding your foundation.
Grow smarter with Qoolo CRM
In biotech, relationships are runway. KOLs. Investigators. Investors. Partners. And most startups track them in spreadsheets. Qoolo CRM connects your content and your contacts in one system - built for life sciences startups, not enterprise pharma. No heavy setup. No IT project. No complex software.
Stop managing contacts. Start managing relationships.
Manage advisors, investors, partners, and HCPs in one place. Segment them intelligently. Send updates directly from Qoolo. See exactly who engaged and when.
Capture every opportunity.
Capture contacts instantly from conferences, sign-up forms, or shared content. No manual entry. No lost business cards.
Follow up with context.
Know which materials sparked interest. See what was opened, read, or revisited. Reach out at the right moment with relevance.
The future of startup content is here,
and it moves at startup speed.
Lean teams are already using it.
It's cheaper than anything else we've tried, and it looks better than anything else we've tried.
Just scan it, and there it is - right on your phone.
When you're in launch mode, you're constantly tweaking the messaging. Before, even a small update could take days or weeks - you'd have to do this, then do that. But when you're at a conference and you realize a message isn't landing or needs to shift, being able to update it on the fly is a game-changer.
Being able to update the messaging while you're in a meeting - sometimes in just minutes - is really impressive. And not just any meeting, but a packed congress where the feedback is immediate. You're listening, making adjustments, and sharing an updated version during the event. That kind of responsiveness just wasn't possible before Qoolo.
I love it! Amazing tool!
The [Qoolo] mobile micro presentations look great and make sense for the time we live in.
Join the startup teams who already use Qoolo.
The answers you're looking for:
For early- and mid-stage life sciences companies, Qoolo is content infrastructure. You need big-pharma output without big-pharma overhead: Qoolo turns pitch decks, trial updates, and board summaries into polished, mobile-first content in hours, not weeks, with no coding, no design team, and no agency delays. The same investor deck, KOL presentation, advisory board pre-read, conference poster, or publication supplement is built once from the same science, instead of rebuilt five times in five formats.
Qoolo is accessible from day one and designed for lean teams. There's no heavy IT setup and no agency dependency required. Founders get credible, branded, referenced, mobile-ready content without expanding their team or adding more tools, so runway stays focused on the science and the milestones that matter.
Qoolo is built around the reality of lean teams doing the work of a much larger organization. Founders fix decks at midnight, the same science gets rebuilt for investors, KOLs, advisors, and conferences, and every subscription is a trade-off against runway. With Qoolo, content is created once and adapted in minutes for every audience, branding and references are applied automatically, and updates flow through one source instead of five files.
Qoolo lets founders build their investor story once and turn it into mobile-first, always-current investor materials: pitch decks, one-pagers, fundraising teasers, term sheet summaries, investor updates, clinical trial data readouts, and regulatory and clinical milestones. Investors can review them in minutes on a phone instead of receiving outdated PDFs, and when safety data, enrollment numbers, or a milestone changes, the update flows through one source and reflects everywhere it appears.
Qoolo replaces long emails with structured investor updates investors can scan, and lets founders share sensitive material through secure links rather than loose files. Founders also see who opened what, so follow-up is informed rather than guesswork.
Qoolo turns advisory board pre-reads, clinical data and safety updates, study protocol reviews, publication and abstract summaries, and post-meeting follow-ups into polished, mobile-first content that lands on a phone the way modern professionals consume information. Most teams are juggling those relationships through spreadsheets, email threads, and one-off PDF attachments; Qoolo replaces that without an agency, a design team, or a heavy CMS behind it.
Because content is built from one source, the same scientific narrative is reshaped quickly for an advisory board, an investigator meeting, or a partner conversation rather than rewritten each time. New data, new milestones, and new positioning flow through automatically, so everyone is looking at the current version. Founders also see which materials sparked interest and which sections were read, so follow-up is grounded in what resonated.
Qoolo is designed to scale with a life sciences company through every stage, rather than locking startups into tools built only for discovery or only for late-stage commercial organizations.
In Discovery & Pre-Clinical, Qoolo establishes a consistent brand and scientific foundation, and delivers investor and KOL communications without agency dependency, so you build trust before you build headcount. Through Clinical & Pre-Launch Planning, the same content infrastructure supports structured clinical trial and regulatory communications, engagement tracking across advisors and investors, and version-controlled safety language and milestone updates, so growth doesn't mean operational chaos. Into Commercialization & Expansion, Qoolo scales into HCP engagement, field enablement, and localization, so you can launch and grow on the same infrastructure without rebuilding your foundation.
Yes. Qoolo is built for that exact scenario. Most early-stage life sciences teams don't have an in-house designer, a content production team, or budget for an agency retainer, and don't want an IT project just to send a polished investor update. Qoolo is browser-based with a drag-and-drop builder, no coding, no design team, and no agency delays, so a founder or lean team member can produce credible, mobile-first, referenced content directly.
Neither is required to get up and running. When extra help is useful for a launch deck, an advisory pre-read, or a conference asset, Qoolo also offers in-house support for an additional charge, or you can work with one of the agencies onboarded to the Qoolo platform.